Clinical Trials on Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea, Republic of
Total 957 results
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Genexine, Inc.CompletedLocally Advanced or Metastatic Solid TumorsKorea, Republic of
-
Seoul National University HospitalMACROGENUnknownNon Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer RecurrentKorea, Republic of
-
Chonnam National University HospitalRoche Pharma AGCompletedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentKorea, Republic of
-
National Cancer Center, KoreaJeil Pharmaceutical Co., Ltd.UnknownAdvanced Non-Small Cell Lung CancerKorea, Republic of
-
Gachon University Gil Medical CenterCompletedAdvanced Non-Small Cell Lung CancerKorea, Republic of
-
PfizerRecruitingMetastatic ALK+ Non Small Cell Lung CancerKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Gachon University Gil Medical CenterCompletedPrevious Treated Metastatic Non-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterUnknownNon-small Cell Lung Cancer MetastaticKorea, Republic of
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel
-
Samsung Medical CenterNot yet recruitingNon-Small Cell Lung Cancer MetastaticKorea, Republic of
-
MedPacto, Inc.AstraZenecaUnknownNon-Small Cell Lung Cancer MetastaticKorea, Republic of
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
National Cancer Centre, SingaporeRecruitingAdvanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore
-
AstraZenecaQuintiles, Inc.CompletedLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)United States
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Txinno Bioscience Inc.RecruitingLocally Advanced (Unresectable) or Metastatic Solid TumorsKorea, Republic of
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
Yonsei UniversityCompletedNon -Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Asan Medical CenterKorea Research Institute of Bioscience & BiotechnologyCompletedNon-small Cell Lung CancerKorea, Republic of
-
Asan Medical CenterEli Lilly and Company; Korean Cancer Study GroupUnknownNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterRecruitingMetastatic Non-Small Cell Lung CarcinomaKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Samsung Medical CenterAstraZenecaCompleted
-
Asan Medical CenterAstraZenecaUnknown
-
Gachon University Gil Medical CenterCompletedNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterNot yet recruitingMetastatic Lung Non-Small Cell Carcinoma | EGFR T790MKorea, Republic of
-
Yonsei UniversityNot yet recruiting
-
Yonsei UniversityRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Asan Medical CenterAstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of
-
The Catholic University of KoreaUnknownNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompletedNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingStage IA Non-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterUnknownStage IIIA Non-small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityCompletedNon Small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of